Surgical Innovations, the Leeds-headquartered medical tech manufacturer, has witnessed its revenues rise to 3.47 million.
For the half a year ended 30 June 2017, the business saw a 14.4% hike in revenues which, it said, were driven by “strong OEM performance and UK sales growth”.
The company stated it was operating against a “more demanding regulatory environment through the industry”.
With that at heart, profit before taxation fell my 0.06 million to 300,000.
Executive Chairman Nigel Rogers said: “Trading inside the loved one of the year to this point has become satisfactory, and continually meet the board expectations.”
There was, however, a rise net cash from 0.72 million during the past year to 1.16 million.
Despite this environment, the business has created numerous key board appointments making the “transformational” buying of Elemental Healthcare.
Mr Rogers added: “Following the latest purchasing Elemental Healthcare Limited additionally, the resulting appointments of Adam Power and David Marsh into the board, we’ve got a wider visual field with the identification of further potential acquisition opportunities, and additional management ability to execution and integration of the further transactions.”